Understanding Deep Infiltrating Endometriosis: A Guide For Medical Professionals

Speciality: Obstetrics and Gynecology


Speaker:

Dr. Asha R.Rao | MD, DGO, FICOG, Infertility Specialist, Obstetrician, Gynecologist

Prof. S Shantha Kumari | MD, DNB, FICOG, FRCPI (Ireland) FRCOG (UK), President FOGSI 2021-2023, Honorary Treasurer FIGO 2021-2023

Dr. Sharda Jain | FIMSA, FICOG, MNAMS (Obstetrtics & Gynaecology) , MD - Obstetrics & Gynaecologist

Description:

A warm welcome to all the medical professionals in this interesting session of ultrasound diagnosis of deep infiltrating endometriosis and its management. In this webinar, the speakers, Dr. Asha R.Rao, Prof. S Shantha Kumari, Dr. Sharda Jain, and other panelists have shared the important facts associated with endometriosis management.

Endometriosis is a disease characterized by the presence of tissue resembling endometrium outside the uterus causing a chronic inflammatory reaction which results in the formation of scar tissue within the pelvis and other parts of the body.

Endometriosis which is located other than in the superficial tissues of the rectovaginal septum and vaginal fornix, the pelvic wall, parametrium, bowel, uterus, or urinary bladder can be called deep infiltrating endometriosis.

Diagnosis of deep endometriosis is difficult and delayed, frequently missed in a routine ultrasound. Thus, transvaginal ultrasound is the first-line imaging modality to investigate endometriosis.

Therefore,  you are going to have an overall knowledge regarding infertility management due to endometriosis. Listen to the webinar, grab the knowledge that is shared and follow HiDoc for more such interesting webinar sessions.
 


See More Webinars @ Hidoc Webinars




Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Cancer during young adulthood carries long-term mental toll, study finds

2.

In postmenopausal women with hormone receptor-positive tumors, obesity increases the risk of breast cancer recurrence.

3.

Surgery after EGFR TKI shows promise in prolonging progression-free survival in metastatic NSCLC

4.

Every cancer is different because of how evolution causes drug resistance and why various cancers require various treatments.

5.

Report: High risk of lung cancer from respirable crystalline silica even below the current occupational exposure limit


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot